Buy & Sell Sanofi SA (SNY) – Sanofi SA Price Today
Aura AI Summary
Key Stats
- $107.71BMarket Cap
- HealthSector
- -12.82%3M Drawdown
- $124.54BEnterprise Value
- 5.39%Dividend Yield
- 3% Buy | 97% SellTrading Activity
- 93 daysTypical Hold Time
Sanofi SA (SNY) is currently valued at a market capitalization of $107.71B, with an enterprise value of $124.54B. Over the past 52 weeks, Sanofi SA has traded between a low of $42.42 and a high of $52.51, highlighting its annual price range. Over the past three months, Sanofi SA has recorded a drawdown of -12.82%, reflecting recent price volatility. Sanofi SA offers a dividend yield of 5.39%, with the most recent dividend of $2.42 paid on 04 May 26. On average, investors hold Sanofi SA for approximately 93 days, indicating typical investor behavior on the platform.
About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Most Recent News
Oura's IPO tests if wellness tech can thrive in public markets amid shifting digital health trends.
Oura Health is preparing for an IPO that could indicate whether public markets are ready to support consumer-focused digital health companies. Unlike earlier wearables focused on hardware sales, Oura emphasizes a subscription model offering health in...
Meta's $125B AI investment sparks investor concern amid rising costs and layoffs
Meta has raised its 2026 capital expenditure guidance to $125-$145 billion, nearly five times last year's $28 billion, focusing heavily on AI infrastructure. Despite strong ad revenue growth, investors worry about the lack of clear AI-driven monetiza...
Space-focused ETF NASA surpasses $1B AUM in weeks, driven by SpaceX hype and commercial space growth.
The Tema Space Innovators ETF (NASA) has rapidly grown from $1 million to over $1 billion in assets under management within just 37 trading days, fueled by investor demand for exposure to SpaceX ahead of its anticipated IPO. Unlike other space ETFs, ...
